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Abstract. Action potential duration (APD) and conduction 
velocity restitution explain the dependence of these param-
eters on the previous diastolic interval (DI). It is considered 
to be an adaptive mechanism for preserving diastole at fast 
heart rates. Hypokalaemia is known to induce ventricular 
arrhythmias that could be prevented by heptanol, the gap 
junction uncoupler, mediated through increases in ventricular 
refractory period (VERP) without alterations in APDs. The 
present study investigated alternans and restitution properties 
during normokalaemia, hypokalaemia alone or hypokalaemia 
with heptanol (0.1 mM) in Langendorff-perfused mouse hearts 
using a dynamic pacing protocol. APD90 alternans were elicited 
in the epicardium and endocardium during normokalaemia. 
Hypokalaemia increased the amplitudes of epicardial APD90 
alternans when basic cycle lengths (BCLs) were ≤65 msec, 
which was associated with increases in maximum APD90 
restitution gradients, critical DIs and APD90 heterogeneity. 
Heptanol (0.1 mM) did not exacerbate or reduce the APD90 
alternans or alter these restitution parameters further. By 
contrast, endocardial APD90 alternans did not show increases 
in amplitudes during hypokalaemia at short BCLs studied, 
and restitution parameters were also unchanged. This was true 
whether in the presence or absence of 0.1 mM heptanol. The 
study demonstrates that anti-arrhythmic effects of heptanol 
exerted during hypokalaemia occurred despite exacerbation 
of APD90 alternans. This would suggest that even in the pres-
ence of arrhythmogenic APD90 alternans, arrhythmias could 
still be prevented by influencing VERP alone. Restitution data 
obtained here by dynamic pacing were compared to previous 
data from S1S2 pacing.
Introduction
Action potential duration (APD) restitution is the normal 
shortening of APD that occurs in response to faster heart rates, 
which is considered to be an adaptive mechanism for preserving 
diastole at such rates (1). It is defined as the dependence of 
APD on the previous diastolic interval (DI). Experimentally, 
APD restitution can be determined using an S1S2 protocol, 
which gradually shortens the interval between the S1 and S2 
stimuli or using a dynamic pacing protocol, which increases 
the heart rate by progressively reducing the basic cycle length 
(BCL). Whilst the two methods can be used to measure APD 
restitution (2), the S1S2 restitution curve is a measure of the 
immediate response to a change in BCL, whereas the dynamic 
restitution curve is a measure of the steady-state response (3).
Hypokalaemia is known to exert pro-arrhythmic effects (4), 
which have been associated with the onset of APD alternans 
in mouse hearts (5). The latter, in turn, has been attributed to 
increases in the steepness of APD restitution, critical DIs (5) 
and maximum APD90 reduction (6). Recently, anti-arrhythmic 
effects of 0.1 and 2 mM heptanol were demonstrated during 
hypokalaemic conditions (6). In our previous experiments, 
restitution analysis performed on data obtained during S1S2 
pacing confirmed the presence of known abnormalities in 
APD restitution, in the absence of any changes in conduction 
velocity (CV) restitution under hypokalaemic conditions. It 
did not detect any effects of heptanol upon APD or CV restitu-
tion. However, this previous study did not explicitly investigate 
the presence or absence of alternans, which may or may not be 
due to abnormal APD restitution, nor did it examine restitu-
tion parameters by dynamic pacing (6), which is currently the 
gold standard. Therefore in the present study, the traditional 
dynamic pacing protocol was used to determine the presence 
or absence of APD and CV alternans and the effects of heptanol 
upon these parameters. This permitted their comparisons with 
values obtained from S1S2 pacing.
Materials and methods
Materials. The present experiments used Krebs-Henseleit 
solution [119 mM NaCl, 25 mM NaHCO3, 4 mM KCl, 1.2 mM 
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KH2PO4, 1 mM MgCl2, 1.8 mM CaCl2, 10 mM glucose 
and 2 mM sodium pyruvate (pH 7.4)] that had been bicar-
bonate‑buffered and bubbled with 95% O2 and 5% CO2 (7). 
Hypokalaemic solution was generated by decreasing the 
amount of KCl added to the Krebs-Henseleit solution to result 
in a total of 3 mM [K+]. Heptanol (Sigma-Aldrich, Dorset, UK; 
density, 0.82 g ml-1) was added directly to the hypokalaemic 
solution to produce a final concentration of 0.1 mM.
Animal model. Wild-type mice (n=13) of the 129 genetic 
background, between 5 and 7 months of age, were used in 
the study. These animals were maintained in plastic cages 
located in the animal facility of the University of Cambridge 
at 21±1˚C with a 12:12‑h light:dark cycle and were permitted 
free access to sterile rodent chow and water at all times. 
The techniques for the preparation of Langendorff-perfused 
murine hearts have been fully described previously (6). 
Mice were sacrificed by cervical dislocation in accordance 
with Sections 1(c) and 2 of Schedule 1 of the UK Animals 
(Scientific Procedures) Act 1986. Their hearts were excised 
and submerged in ice-cold Krebs-Henseleit solution, followed 
by removal of the surrounding lung tissue. The aorta was 
cannulated using a tailor-made 21-gauge cannula prefilled 
with ice-cold buffer, secured using a micro-aneurysm clip 
(Harvard Apparatus, Kent, UK) and attached to the perfu-
sion system. Retrograde perfusion was started at a rate of 
2‑2.5 ml min-1 using a peristaltic pump (Watson-Marlow 
Bredel pumps model 505S; Falmouth, Cornwall, UK) with the 
perfusate successively passing through 200‑ and 5‑µm filters, 
and heated to 37˚C using a water jacket and circulator. The 
majority of the hearts regained spontaneous contractions and 
pink colour (~90%). These were subsequently used for experi-
mentation. The remaining hearts were discarded. Perfusion 
with Krebs-Henseleit solution was maintained for a further 
20 min before pharmacological manipulation to minimise 
residual effects of endogenous catecholamine release.
Stimulation protocol. Electrical stimulation of the right 
ventricular epicardium was carried out immediately following 
the start of perfusion using paired platinum electrodes (1 mm 
interpole distance) using regular pacing. This was set at a BCL 
of 125 msec (8 Hz), which is close to the in vivo heart rate of the 
mouse (8), allowing rate-dependent differences in APDs to be 
excluded. Square wave pulses of 2-msec duration at a stimula-
tion voltage set to three times the excitation threshold (Grass S48 
Stimulator; Grass-Telefactor, Slough, UK) were used, thereby 
allowing direct comparisons with previous mouse studies of 
arrhythmogenesis (9-12). The dynamic pacing protocol used to 
detect alternans involved delivering 100 stimuli at a constant 
BCL. The BCL was initially set at 180 msec and was decreased 
by 5 msec every 100 stimuli until a value of 50 msec was reached.
Recording parameters. The following parameters were 
measured: i) APD90 alternans, which were calculated by 
beat-to-beat differences in APD90; ii) APD90 restitution gradient 
obtained from restitution curves plotting APD90 against the 
previous DI, assuming its maximum value at the shortest 
BCL studied; iii) critical DI, DIcrit, defined as the DI at which 
the gradient of the APD90 restitution curve reaches unity; 
iv) maximum APD90 reduction, a measure of APD90 restitution 
heterogeneity, defined as the maximum APD90 reduction 
observed between the longest and shortest BCL studied; v) CV 
alternans, which were calculated by beat-to-beat differences in 
CV; vi) CV restitution gradient obtained from restitution curves 
plotting CV against the previous DI, assuming its maximal 
value at the shortest BCL studied; vii) CV restitution curve time 
constant, τ; viii) maximum CV reduction, a measure of CV 
restitution heterogeneity, defined as the maximum CV reduction 
observed between the longest and shortest BCL studied.
Previous studies have associated arrhythmogenesis with 
three changes in CV restitution: Increased maximum CV 
restitution gradients, increased time constants of the fitted 
curves (τ, reflecting reduced CV restitution gradients) (13,14) 
and increased CV heterogeneity, defined as the maximum CV 
reduction observed during the dynamic pacing protocol (15). 
The onset of alternans has previously been attributed to 
increases in the gradients of restitution curves plotting APD90 
against the preceding DI and DIcrit (5). The present experi-
ments therefore obtained mean values for APD90 and DI from 
all hearts (n=6) at all of the BCLs studied, and fitted them 
with an exponential function of the form y = y0 + Ae-x/τ by a 
least squares method using a Levenberg-Marquardt algorithm. 
y and x represent mean APD90 and mean DI, respectively, 
whereas y0, A and τ are constants. The gradient is given by: 
assuming its maximal value at the shortest BCL studied.
Statistical analysis. All values are expressed as the 
mean ± standard error. Different experimental groups were 
compared by one‑way analysis of variance. P<0.05 was 
Figure 1. Alternations in conduction velocity and action potential duration 
observed at a range of basic cycle lengths using a dynamic pacing protocol. 
MAP recordings obtained from the (A-C) epicardium under control, and 
hypokalaemic conditions prior and subsequent to the introduction of 0.1 mM 
heptanol. MAP, monophasic action potential.
  A
  B
  C
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considered to indicate a statistically significant difference. 
P<0.05 was considered to indicate a statistically significant 
difference. In figures, *, ** and *** denote P<0.05, 0.01 and 
0.001, respectively.
Results
Initial experiments to quantify the APD90 alternans. The 
initial experiments quantified APD90 alternans, which have 
previously been associated with arrhythmogenesis (5), using 
a dynamic pacing protocol under normokalaemic and hypo-
kaalemic conditions, and hypokalaemia in the presence of 
0.1 mM heptanol. This protocol delivered 100 stimuli at a 
constant BCL, at an initial value of 180 msec and decreased by 
5 msec every 100 stimuli until a value of 50 msec was reached. 
It was not possible to quantify alternans at short BCLs using 
this protocol in the presence of 2 mM heptanol as ventricular 
refractory periods (VERPs) increased and CV reduced in a 
time-dependent manner without reaching a stable value, 
eventually resulting in conduction block within 4 min of 
its introduction, preventing a 1:1 stimulus-response. Such 
effects for 2 mM heptanol on CV and VERP are consistent 
with those previously reported under normokalaemic condi-
tions (11).
Monophasic action potential (MAP) recordings. Example 
traces of MAP recordings obtained from the epicardium are 
shown in Fig. 1 under three pharmacological conditions (n=6). 
The epicardial (Fig. 2A-C) and endocardial (Fig. 2D-F) APD90 
alternans increased in magnitude as BCL decreased from 180 
to 50 msec under all three cases. However, hypokalaemia 
significantly increased the alternans at BCLs ≤65 msec in the 
epicardium (P<0.05); however, no equivalent effects in the 
endocardium were observed, and none of these values were 
further altered by 0.1 mM heptanol whether at the epicardium 
or endocardium (P>0.05).
Figure 2. APD90 alternans amplitudes. Amplitudes of APD90 alternans obtained at a range of BCLs during a dynamic pacing protocol from the (A-C) epicar-
dium under control and hypokalaemic conditions prior and subsequent to the introduction of 0.1 mM heptanol, and from the (D-F) endocardium under the same 
conditions. The amplitudes of epicardial APD90 alternans were significantly increased by hypokalaemia at BCLs ≤65 msec (analysis of variance, P<0.05) and 
not altered further by 0.1 mM heptanol (P>0.05). By contrast, mp significant difference was observed for those of endocardial APD90 alternans between these 
conditions (P>0.05). APD, action potential duration; BCL, basic cycle length.
  A   B   C
  D   E   F
Table I. Parameters for epicardial APD90 restitution curves 
obtained during dynamic pacing. APD, action potential 
duration.
Condition yo, msec A, msec τ, msec
Control 39.5±6.4 ‑30.3±6.2 25.0±5.6
Hypo K+ 53.2±2.4 ‑50.5±4.7 14.6±3.8
Hypo K++0.1 mM 57.6±2.2 ‑59.4±2.5 10.4±1.4
heptanol
APD, action potential duration.
Table II. Parameters for endocardial APD90 restitution curves 
obtained during dynamic pacing. APD, action potential 
duration.
Condition yo, msec A, msec τ, msec
Control 47.2±4.8 ‑59.1±11.5 55.0±15.2
Hypo K+ 60.8±21.2 ‑60.2±21.4 53.2±26.1
Hypo K++0.1 mM 83.5±27.4 ‑87.3±28.2 64.9±18.5
heptanol
APD, action potential duration.
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APD restitution curves. Fig. 3 shows the restitution curves 
(solid lines, left ordinates) along with their gradients 
(broken lines, right axes) obtained under control, hypoka-
laemic conditions before and after introduction of 0.1 mM 
heptanol from the epicardium (Fig. 3A-C) and endocardium 
(Fig. 3D-F). The grey boxes indicate ranges of DI values 
at which such gradients exceed unity (i.e., DIs < DIcrit). 
The fitted parameters for the epicardial and endocardial 
APD restitution curves are detailed in Tables I and II, 
respectively. APD90 decreased as DI decreased under all 
pharmacological conditions. The maximal APD90 restitu-
tion gradients, DIcrit and maximum APD90 reduction at the 
epicardium (clear bars, Fig. 4A-C) were all significantly 
increased by hypokalaemia from 0.8±0.2 to 2.1±0.4 (P<0.01), 
from ‑0.4±5.4 to 14.9±1.3 msec (P<0.05) and from 27.1±4.5 
to 45.5±3.6 msec (P<0.05), respectively. None of these were 
further altered by 0.1 mM heptanol (P>0.05). By contrast, 
the maximal restitution gradients, DIcrit and maximum APD90 
reduction at the endocardium (Fig. 4D‑F) were not signifi-
cantly altered by hypokalaemia alone or by 0.1 mM heptanol 
(P>0.05).
CV alternans. The presence of CV alternans would exacer-
bate any alternation in APD90, potentially further increasing 
arrhythmogenic risk. Therefore, CV alternans were quantified 
over the same range of BCLs for the epicardium (Fig. 5A‑C) 
and endocardium (Fig. 5D‑F). In the epicardium, there 
was an increase in their magnitudes from 0.0008±0.0003 
to 0.0031±0.0008 m/sec (Fig. 5A) as BCL decreased from 180 
to 50 msec under the control conditions. However, these values 
were not altered at any BCL under hypokalaemic conditions 
alone (Fig. 5B) or following the introduction of 0.1 mM 
heptanol (Fig. 5C). In the endocardium, CV alternans similarly 
increased in magnitude with decreasing BCLs over the same 
range under control conditions (Fig. 5D), and they were not 
altered further by either hypokalaemia alone (Fig. 5E) or in the 
presence of 0.1 mM heptanol (Fig. 5F) (P>0.05 in all cases).
CV restitution curves. Fig. 6 shows CV restitution curves 
(solid lines, left ordinates) obtained under control and hypo-
kalaemic conditions before and after introduction of 0.1 mM 
heptanol from the epicardium (Fig. 6A-C) and endocardium 
(Fig. 6D‑F). The fitted parameters are summarized in 
Table III. Parameters for epicardial conduction velocity resti-
tution curves obtained during dynamic pacing.
Condition yo, m/sec A, m/sec τ, msec
Control 0.29±0.09 -0.22±0.089 68.3±6.9
Hypo K+ 0.20±0.01 ‑0.11±0.019 37.5±12.0
Hypo K++0.1 mM 0.18±0.02 -0.12±0.031 20.2±4.4
heptanol
Table IV. Parameters for endocardial conduction velocity res-
titution curves obtained during dynamic pacing.
Condition yo, m/sec A, m/sec τ, msec
Control 0.22±0.02 ‑0.13±0.030 34.6±3.5
Hypo K+ 0.17±0.01 -0.09±0.029 40.4±12.8
Hypo K++0.1 mM 0.27±0.06 ‑0.18±0.053 78.6±38.7
heptanol
Figure 3. Epicardial and endocardial APD90 restitution curves. Restitution curves plotting APD90 against the preceding DI obtained from the (A-C) epicardium 
under control and hypokalaemic conditions prior and subsequent to the introduction of 0.1 mM heptanol and from the (D-F) endocardium under the same 
conditions. Curves are fitted with mono‑exponential growth functions obtained by least‑squares fitting to the mean values of APD90 and DI (solid lines, left 
ordinates). Gradients were obtained by differentiation of the fitted functions (broken lines, right axes). The grey boxes indicate the ranges of DI values at which 
such gradients exceed unity. APD, action potential duration; DI, diastolic interval.
  D   E   F
  B  A   C
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Tables III and IV. CV decreased as DI decreased under all 
pharmacological conditions. In the epicardium, hypoka-
laemia alone did not appear to significantly influence either 
maximum CV restitution gradients (Fig. 7A) or the time 
constant τ (Fig. 7B) (P>0.05). By contrast, hypokalaemia 
with 0.1 mM heptanol increased the maximum CV restitution 
gradients from 1.6±0.3 to 5.2±1.4 (P<0.05) and decreased τ 
from 88.3±20.2 to 20.2±4.37 msec (P<0.05). The maximum 
CV reductions were not significantly different between the 
three pharmacological conditions (Fig. 7C) (P>0.05). In the 
endocardium, no difference was observed in any of the CV 
restitution parameters between these pharmacological condi-
tions (Fig. 7D‑F; P>0.05).
Finally, it was possible to compare the restitution 
parameters obtained in this study using the dynamic pacing 
protocol with those previously obtained during S1S2 pacing. 
The latter results are reproduced in the present study (with 
permission) and represented by filled bars in Fig. 4 (APD 
data) and Fig. 7 (CV data). Significant differences in values 
obtained during dynamic pacing and S1S2 pacing data are 
denoted by asterisks. No difference was observed for APD90 
restitution gradients obtained by dynamic pacing and S1S2 
Figure 5. CV alternans amplitudes. Epicardial CV alternans amplitudes obtained at a range of basic cycle lengths during a dynamic pacing protocol obtained 
from the (A-C) epicardium under control and hypokalaemic conditions prior and subsequent to the introduction of 0.1 mM heptanol, and from the (D-F) endo-
cardium under the same conditions. No significant differences were observed between these conditions (P>0.05). CV, conduction velocity; ms, msec.
  A   B   C
  D   E   F
Figure 4. Maximum APD90 restitution gradients, critical diastolic intervals and maximum APD90 reductions obtained from the (A-C) epicardium and 
(D‑F) endocardium using dynamic pacing (clear bars) and S1S2 pacing (filled bars). APD, action potential duration; Hep, heptanol.
  A   B   C
  D   E   F
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pacing whether in the epicardium or endocardium under 
the three pharmacological conditions (P>0.05). By contrast, 
epicardial DIcrit values obtained from dynamic pacing were 
significantly larger than those obtained during S1S2 pacing 
during hypokalaemia alone and in the presence of 0.1 mM 
heptanol (P<0.01). Endocardial DIcrit values were not 
significantly different by the pacing method under the three 
pharmacological conditions studied. Notably, maximum 
APD90 reduction was significantly larger when dynamic 
pacing was used whether in the epicardium (Fig. 4C) or 
endocardium (Fig. 4F) for all pharmacological conditions 
studied. For CV restitution data, maximum CV restitution 
gradients in the epicardium were larger when obtained using 
S1S2 pacing compared to dynamic pacing for control and 
hypokalaemia alone (P<0.05), but not for hypokalaemia in 
the presence of 0.1 mM heptanol (P>0.05). This is reflected 
by shorter time constants τ using S1S2 pacing. As opposed 
to the maximum APD reduction, maximum CV reduction in 
Figure 7. Maximum CV restitution gradients, time constants of restitution curves and maximum CV reductions from the (A-C) epicardium and (D-F) endo-
cardium using dynamic pacing (clear bars) and S1S2 pacing (filled bars). CV, conduction velocity; Hep, heptanol.
  A   B   C
  D   E   F
Figure 6. CV restitution curves. Restitution curves plotting CV against the preceding DI obtained from the (A-C) epicardium under control and hypokalaemic 
conditions prior and subsequent to the introduction of 0.1 mM heptanol, and from the (D‑F) endocardium under the same conditions. Curves are fitted with 
mono‑exponential growth functions obtained by least‑squares fitting to the mean values of CV and DI (solid lines, left ordinates). Gradients were obtained by 
differentiation of the fitted functions (broken lines, right axes). CV, conduction velocity; DI, diastolic interval; ms, msec.
  A   B   C
  D   E   F
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either the epicardium or endocardium did not vary between 
the two pacing methods under the three pharmacological 
conditions (P>0.05).
In summary, all the aforementioned findings demonstrate 
that hypokalaemia increased the magnitudes of epicardial 
APD90 alternans at short DIs associated with increased restitu-
tion gradients, DIcrit and APD heterogeneity, without effects on 
CV restitution. Heptanol at 0.1 mM did not further influence 
APD or CV restitution. The dynamic pacing and S1S2 pacing 
are equally effective for eliciting abnormal restitution.
Discussion
Abnormal electrical restitution predisposes to ventricular 
arrhythmogenesis through the production of arrhythmogenic 
alternans. Different protocols can be used to examine different 
aspects of restitution: S1S2 pacing can be used to measure 
the immediate response of cardiac tissue to a change in the 
BCL, whereas dynamic pacing can be used to determine the 
steady-state response. In the present study, APD and CV resti-
tution was examined in normokalaemic and hypokalaemic 
conditions alone and hypokalaemia in the presence of 0.1 mM 
heptanol, a gap junction inhibitor, using a dynamic pacing 
protocol. Subsequently, this permitted comparisons with 
previously published results on S1S2 restitution under similar 
experimental conditions (6).
Experiments using dynamic pacing protocol showed 
increasing amplitudes of epicardial and endocardial APD90 
alternans with progressive shortenings in BCLs under control 
and hypokalaemic conditions prior and subsequent to the 
introduction of 0.1 mM heptanol. Hypokalaemia significantly 
increased the amplitudes of APD90 alternans at BCLs ≤65 msec 
in the epicardium but not the endocardium, in agreement with 
previous findings (5). These were not further altered by 0.1 mM 
heptanol, suggesting that it was able to exert anti-arrhythmic 
effects despite the persistence of arrhythmogenic APD alter-
nans. In the present study, it was not possible to investigate 
alternans or restitution properties using the dynamic pacing 
protocol during exposure to a higher concentration of heptanol 
(2 mM) due to its actions in increasing VERPs and producing 
conduction block within short periods of time, resulting in the 
breakdown of the 1:1 stimulus-response. This is consistent with 
its previously reported inhibitory effects on sodium channels at 
2 mM resulting in progressive reductions in CV and ultimately 
conduction block (16). However, it appeared to be possible to 
investigate the effects of 2 mM heptanol previously using S1S2 
pacing as this protocol only lasts <120 sec (6), whereas the 
dynamic pacing protocol used in our study lasted ≥5 min.
Restitution analysis demonstrated hypokalaemia increased 
the maximum APD90 restitution slopes and DIcrit in the epicar-
dium but not in the endocardium, in agreement with previous 
findings (5). By contrast, the arrhythmogenesis observed in 
guinea pig hearts during hypokalaemia was also associated 
with APD90 alternans but this was despite restitution gradi-
ents becoming less steep (17). Notably, in guinea pig hearts, 
endocardial APD90 restitution gradients were also increased 
by hypokalaemia (17), as opposed to in canine (18) or mouse 
hearts in which they were unaffected (5,6). APD90 restitu-
tion gradients and DIcrit were not further altered by 0.1 mM 
heptanol.
The presence of CV alternans would exacerbate any 
alternation in APD90, potentially further increasing arrhyth-
mogenic risk, by converting spatially concordant alternans 
to spatially discordant alternans. CV alternans increased in 
magnitude with decreasing BCLs decreased but these were 
not further exacerbated by hypokalaemia alone, nor further 
altered by 0.1 mM heptanol. Furthermore, alterations in CV 
restitution gradients, time constants of fitted restitution curves 
or increased CV heterogeneity (defined as maximum CV 
reduction at the longest and shortest BCL studied) may predis-
pose to arrhythmias (14,15). Restitution analysis demonstrated 
increased CV restitution gradients and decreased without 
altering either CV alternans amplitudes or CV heterogeneity 
during hypokalaemia. No further changes were observed 
following 0.1 mM heptanol treatment. These results comple-
ment the previous findings associating arrhythmogenesis 
with increased CV alternans amplitudes and reduced CV 
restitution slopes using theoretical ion channel models (13) and 
experimentally using the electromechanical uncoupling drug 
diacetyl monoxime (14). By contrast, the arrhythmias induced 
by the electromechanical uncoupling drug methoxyverapamil 
(D600) in rabbit hearts were associated with increased CV 
heterogeneity (15).
The present experiments demonstrate that, in general, APD 
and CV restitution gradients obtained during dynamic pacing 
are in agreement with those obtained previously using an S1S2 
protocol (5,6), with two differences observed between the two 
methods. Firstly, the present study found that maximum APD90 
reduction was larger for dynamic pacing compared to for S1S2 
pacing. By contrast, in guinea pig hearts, APD restitution gradi-
ents obtained using the S1S2 method were larger than those 
obtained during dynamic pacing (19). In the present study, the 
apparent lack of difference may be due to the low statistical 
power to detect differences as a small number of hearts was used. 
Secondly, dynamic pacing revealed increased CV restitution 
gradients in the presence of 0.1 mM heptanol during hypoka-
laemia, a finding that was not apparent using S1S2 pacing (6).
In conclusion, the present study compared results of resti-
tution analysis using the dynamic pacing technique with those 
obtained previously using a S1S2 protocol. It found that resti-
tution data obtained by the two methods are largely agreeable. 
This would support the use of S1S2 protocol for examining 
restitution and justifying its use in experimental and clinical 
settings, which was previously discussed (19). Certain caution 
must be taken when interpreting restitution data obtained from 
S1S2 pacing, as a dynamic pacing protocol was shown to be 
more representative of the APD dynamics observed at high 
heart rates (20,21). Although it is the gold standard, dynamic 
pacing is often avoided in clinical situations as regular pacing 
at high heart rates can induce myocardial ischaemia (22,23). 
The advantage of the PES protocol is therefore safety in a clin-
ical setting, as this does not rely on tachycardia pacing (19,21). 
Using such a protocol, abnormal electrical restitution, which 
can predispose to the development of arrhythmogenic alter-
nans, can be determined (24).
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